Allosteric Regulation and Inhibition of Coronavirus 3CLpro Revealed by HDX-MS

Ning Song1,2, Wen Zheng3, Bin Song4

  • 1Immunological Disease Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Rd, 201203, Shanghai, PR China.

Insights

Targeting coronavirus 3-chymotrypsin-like proteases (3CLpro) is key for drug development. The allosteric inhibitor Gastrodenol disrupts 3CLpro dimerization, suggesting its potential as a broad-spectrum antiviral drug.

Area of Science:

  • Virology
  • Biochemistry
  • Drug Discovery

Background:

  • Coronaviruses (CoVs) cause severe respiratory illnesses globally.
  • 3-chymotrypsin-like proteases (3CLpro) are essential for CoV maturation and activity.
  • Maintaining 3CLpro's dimeric form is critical for its function, making it a viable drug target.

Purpose of the Study:

  • To investigate the allosteric regulation mechanism of 3CLpro dimerization.
  • To explore the potential of Gastrodenol as a broad-spectrum anti-betacoronavirus agent.

Main Methods:

  • Hydrogen/deuterium exchange mass spectrometry (HDX-MS) to study protein dynamics.
  • Analysis of 3CLpro mutants and FLAG-tagged constructs.
  • Molecular dynamics (MD) simulations to elucidate drug-target interactions.

Main Results:

  • N-terminal FLAG tag and monomeric SARS-CoV-2 3CLpro mutants showed increased deuterium exchange at the dimer interface.
  • Gastrodenol binding induced monomerization in most betacoronavirus 3CLpros.
  • MD simulations revealed Gastrodenol disrupts dimer interface hydrogen bonds in SARS-CoV-2 3CLpro.

Conclusions:

  • Allosteric regulation of 3CLpro dimerization is a druggable mechanism.
  • Gastrodenol's ability to induce monomerization suggests it could be a potent antiviral.
  • Gastrodenol shows promise as a broad-spectrum therapeutic for betacoronavirus infections.

Related Concept Videos

Allosteric Regulation01:08

Allosteric Regulation

Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.9K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K